John Smith - Articles and news items

FDA approves updated prescribing information for Tradjenta® (linagliptin) tablets

Industry news, News / 17 August 2012 / Eli Lilly and Company

Updated label also includes data on adult patients with type 2 diabetes…

New Phase 3 data for Tradjenta® (linagliptin) tablets

Industry news, News / 24 May 2012 / Eli Lilly and Company

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company announced Phase 3 study results…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+